PubMed Health⌕ Search

Biomedical subjects

E Rau

Publications and source records attributed to E Rau.

11 recordsLinked to original sources
PubMed1980

A simple method for the isolation of phages from Listeria monocytogenes.

By application of a combined mitomycin-/heat treatment after freezing, 7 out of 29 Listeria monocytogenes strains which were found to be non-phage carriers by UV irradiation could release phages. Propagation of the obtained phages was promoted by storage at 4 degrees C. Apart from TNSA plates the application of chocolate plates appears to be necessary in order to study these phages.

Animals↗
PubMed1975

A diurnal rhythm of incorporation of L-[3H] leucine in myocardium of the rat.

The influence of the time of day on myocardial protein synthesis and hypertrophy was examined in rats entrained to a 12-12 hr light-dark cycle. Analysis of ventricular weight to body weight ratio indicates that isoproterenol was a more effective stimulus of hypertrophy if given during the dark period, when the rat is most active, than when administered during the light hours. The difference was not attributed to alterations in percent water of the myocardium or nutritional status of the animal. Differential incorporation of labeled leucine into protein throughout the day indicated that myocardial protein may be synthesized at the greatest rate late in the light period with least synthesis occurring during the late hours of the dark period. The implications of these results are discussed.

Animals↗
PubMedDate not supplied

Treatment of acute tonsillitis with a fixed-combination herbal preparation.

In an observational study involving 10 non-hospital-affiliated physicians, 48 patients between 6 and 73 years of age with symptoms of acute tonsillitis were treated with either a liquid or tablet formulation of a herbal compound of Phytolacca, Guajacum, and Capsicum. More than half of the patients reported marked alleviation of the principal symptom, moderate or severe difficulty in swallowing, within the first 5 days of treatment. Comparable improvements occurred in other outcome measures, including earache, headache, and fatigue. No adverse side effects were reported.

Acute Disease↗
PubMedDate not supplied

[Glycosaminoglycanpolysulfate (GAGPS, Arteparon) for basic therapy of arthrosis. I. Comparative studies, Arteparon forte and physical therapy vs. physical therapy alone].

Glycosaminoglycan polysulphate (GAGPS, Arteparon) is effective as a fundamental therapeutic agent in arthrosis (osteoarthritis). Patients with gonarthrosis and coxarthrosis of activity grade II received intramuscular Arteparon forte injections and physical therapy (group 1, n = 69) or physical therapy only (group 2, n = 46). In group 1 23 patients (33.3%) became free of pain as compared to 3 patients (6.5%) in group 2. No therapeutic success was obtained in 6 patients of group 1 (8.7%) and in 14 individuals (30.4%) of group 2.

Adult↗
PubMedDate not supplied

[Glycosaminoglycanpolysulfate (GAGPS, Arteparon) for basic therapy of arthrosis. II. Comparative studies, Arteparon forte and physical therapy vs. physical therapy alone; late results].

Five to 9 months after a comparative study of 2 groups of patients with coxarthrosis and gonarthrosis, 69 individuals (group 1) receiving Arteparon forte injections and physical therapy and 46 persons (group 2) with physical therapy only, questioneer with specific questions was sent out. From 72 questioneers mailed 55 were returned to the investigators of the study. 53 questioneers were suitable for evaluation: 40 in the group 1 and 13 in group 2. 62.5% of the patients in group 1 described their condition improved as compared to 30.8% in group 2. In 46.1% of the patients in group 2 the condition had deteriorated; this occurred in only 17.5% of group 1.

Adult↗